Double‐blind placebo‐controlled trial of the effect of omalizumab on basophils in chronic urticaria patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2222|48|2|196-204

ISSN： 0954-7894

Source： CLINICAL & EXPERIMENTAL ALLERGY, Vol.48, Iss.2, 2018-02, pp. : 196-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized, Double‐Blind, Placebo‐Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 7, 2015-07 ,pp. : 1848-1857

John Wiley & Sons Inc

Access to resources Recommend Favorite

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial

By Lems W.   Lodder M.   Lips P.   Bijlsma J.   Geusens P.   Schrameijer N.   Ven C.   Dijkmans B.  

Osteoporosis International, Vol. 17, Iss. 5, 2006-05 ,pp. : 716-723

Springer Publishing Company

Access to resources Recommend Favorite

A double-blind, double-dummy, randomized, placebo-controlled trial to evaluate the effect of statin therapy on triglyceride levels in Mexican hypertriglyceridemic patients

By Talavera Juan-Osvaldo   Martinez Gustavo   Cervantes Jose-Luis   Marin Javier-Aguila   Rodriguez-Briones Ignacio   Gonzalez Jose-Gerardo   Ocampo Rodolfo   Sanchez-Mijangos Hector   Bernal-Rosales Laura P.   Polanco Ana  

Current Medical Research and Opinion, Vol. 29, Iss. 4, 2013-04 ,pp. : 379-386

Informa Healthcare

Access to resources Recommend Favorite

Possible therapeutic effect of carvacrol on asthmatic patients: A randomized, double blind, placebo‐controlled, Phase II clinical trial

By  

PHYTOTHERAPY RESEARCH, Vol. 32, Iss. 1, 2018-01 ,pp. : 151-159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

By Barzilai Nir   Guo Hua   Mahoney Erin M.   Caporossi Suzanne   Golm Gregory T.   Langdon Ronald B.   Williams-Herman Debora   Kaufman Keith D.   Amatruda John M.   Goldstein Barry J.   Steinberg Helmut  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 1049-1058

Informa Healthcare

Access to resources Recommend Favorite